New systemic treatment options for metastatic renal-cell carcinoma in the era of targeted therapies
Advances in understanding the biology and genetics of renal-cell carcinomas have led to the development of novel targeted therapies for the treatment of metastatic renal-cell cancer. Previously the systemic approaches were limited to cytokine therapies that were modest in their clinical benefits and at the expense of significant toxicities. Investigational treatments with allogeneic bone marrow transplantation were equally toxic and resulted in significant morbidity and mortality. The...[Show more]
|Collections||ANU Research Publications|
|Source:||Asia-Pacific Journal of Clinical Oncology|
|01_Tan_New_systemic_treatment_options_2010.pdf||159.77 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.